Epidemiological studies have shown that obesity is a risk factor for breast cancer in postmenopausal women, when the tumors are frequently estrogen receptor (ER)-positive and a major mechanism involves elevated aromatase activity and estrogen production in adipose tissue stromal cells [1,2,3]. Here, CYP19A1 is linked to obesity due to melanocortin 4 receptor deficiency.